For much of the 2025 season, Jak Crawford has been considered the next American hopeful for Formula One. The last American to compete in the pinnacle of motorsport was Logan Sargeant, who raced for ...

The FDA updated the indication of the JAK inhibitor upadacitinib (Rinvoq) in inflammatory bowel disease (IBD) to account for cases where a patient may not be appropriate for a TNF blocker, drugmaker ...

Maddie Fisher is a writer, journalist and game developer. She was born and raised on the east coast, having started working in games journalism over fifteen years ago. She tends to enjoy musical ...

Please provide your email address to receive an email when new articles are posted on . JAK inhibition carried higher malignancy risk vs. biologic DMARDs. Malignancy risk was seen in older patients ...

Some previous studies, including the ORAL Surveillance randomized trial, have shown moderately greater cancer risks with JAK inhibitors versus TNF inhibitors. But some other analyses of real-world ...

Moises Mendez II is an associate editor at Out Magazine based in Brooklyn, New York. He covers internet culture and entertainment, including television, movies, music, and more. Before joining Out, he ...

Please provide your email address to receive an email when new articles are posted on . JAK inhibitors were not linked to increased cardiovascular complications vs. TNF inhibitors or other DMARDs in ...

Jak Malone has won the 2025 Tony Award for Best Performance by an Actor in a Featured Role in a Musical for Operation Mincemeat: A NEW MUSICAL. Attention Mincefluencers! The acclaimed new musical ...

Halfway into Broadway’s new WWII farce Operation Mincemeat, Hester Leggatt, a stern secretary, stops the show in its tracks with “Dear Bill.” The six-minute ode feels like a separate production from ...

GameSpot may get a commission from retail offers. This week's Triple- Initiative covered a wide range of genres, but for anyone looking for a retro-inspired platformer, then Duskfade was likely the ...

Ruxolitinib cream shows comparable efficacy to systemic therapies in reducing disease severity in moderate atopic dermatitis, with significant BSA reduction over 7.4 months. Abrocitinib demonstrates ...

Janus kinase inhibitors (JAKis) are an important treatment option for people with chronic inflammatory diseases such as rheumatoid arthritis, psoriasis, Crohn's disease or ulcerative colitis. Since ...